10 Best Foreign Stocks With Dividends For Passive Income

4. Medtronic plc (NYSE:MDT)

Dividend Yield as of February 3: 3.20%

Number of Hedge Fund Holders: 60

Medtronic plc (NYSE:MDT) is a manufacturer and seller of medical devices for healthcare systems, doctors, and patients worldwide. The company is focused on Cardiovascular, Neuroscience, and Medical Surgical device portfolios. It currently has over 190 active clinical trials, and more than 43,000 active patent matters, and it has allocated around $2.7 billion to R&D.

In the fourth quarter of 2024, Medtronic plc (NYSE:MDT) reported revenue growth of 5%, which was 50 basis points above the company’s guidance. The earnings per share of $1.26 also exceeded the guidance, albeit slightly. The company’s robust financials were supported by double-digit growth in diabetes, high single-digit growth in neuroscience, and mid-single-digit growth in cardiovascular. MDT continues to prioritize dividends and share repurchases, as well as tuck in M&As. The company paid a $0.70 per share quarterly dividend on January 10.  Medtronic plc (NYSE:MDT) is on its way to becoming a dividend king, having raised its dividends for 47 consecutive years.

On January 13, 2025, Medtronic plc (NYSE:MDT) announced that it had met the EU Medical Device Regulation standards and received the CE Mark approval in the EU and the UK for two deep brain stimulation devices for Parkinson’s patients. Medtronic is the market leader in deep brain stimulation (DBS) innovation, and the company is committed to improving neurological care.

Insider Monkey’s Q3 data shows that Medtronic plc (NYSE:MDT) was part of 60 hedge fund portfolios, compared to 52 in the last quarter. Jean-Marie Eveillard’s First Eagle Investment Management is the leading stakeholder of the company, with 9.7 million shares valued at nearly $879 million.